跳至主要内容
临床试验/JPRN-UMIN000012362
JPRN-UMIN000012362已完成未知

A prospective study of the efficacy and safety of Denosumab for the prevention of osteoporosis in malignant lymphoma patients treated with prednisolone-containing chemotherapy - A prospective study of the efficacy and safety of Denosumab for the prevention of osteoporosis in malignant lymphoma patients treated with prednisolone-containing chemotherapy (SMUIM4-NHL01)

Department of Medical Oncology and Hematology, Sapporo Medical University, School of Medicine0 个研究点目标入组 30 人开始时间: 2013年11月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Uncontrolled hepatic disease, renal disease, heart disease, lung disease, diabetes mellitus, hypertention and infectious disease Active concomitant malignancy Severe psychiatric disorders Women who are pregnant or in lactation Hypersensitivity to the denosumab Dental therapy during this trial Current hypocalcemia Patient judged inappropriate for this study by the physicians

研究者

发起方
Department of Medical Oncology and Hematology, Sapporo Medical University, School of Medicine

相似试验